Global Intravenous Iron Therapy Supply, Demand and Key Producers, 2023-2029
Page: 111
Published Date: 02 Sep 2023
Category: Medical Devices & Consumables
PDF Download
Get FREE Sample
Customize Request
- Description
- Table of Contents
- Table of Figures
- Research Methodology
- Companies Mentioned
- Related Reports
- Product Tags
Description
The global Intravenous Iron Therapy market size is expected to reach $ 1943.1 million by 2029, rising at a market growth of 6.3% CAGR during the forecast period (2023-2029).
The global intravenous iron therapy market refers to the market for intravenous administration of iron for the treatment of iron deficiency anemia (IDA) and other conditions that require iron supplementation. Intravenous iron therapy is used when oral iron supplements are ineffective or cannot be tolerated by patients.
Iron deficiency anemia is a common condition characterized by low levels of circulating red blood cells due to insufficient iron supply. It can result from various factors such as poor dietary intake, chronic blood loss, malabsorption, and pregnancy. Intravenous iron therapy is a proven and effective method for rapidly replenishing iron stores and correcting iron deficiency.
The global market for intravenous iron therapy is primarily driven by factors such as the high prevalence of iron deficiency anemia worldwide, increasing awareness about the benefits of intravenous iron therapy, developments in iron formulations and delivery systems, and the growing number of patients requiring iron supplementation.
Intravenous iron therapy offers several advantages over oral iron supplements, including faster and more reliable iron absorption, avoidance of gastrointestinal side effects, and the ability to deliver larger doses in a shorter period. It is commonly used in various clinical settings, including hospitals, primary care clinics, and specialty centers.
Geographically, North America and Europe hold a significant share in the global intravenous iron therapy market due to the high prevalence of iron deficiency anemia, well-established healthcare systems, and a large patient population. The Asia Pacific region is expected to witness substantial growth due to increasing healthcare awareness, improving infrastructure, and rising prevalence of iron deficiency anemia.
Key players in the global intravenous iron therapy market include pharmaceutical companies specializing in iron formulations, medical device manufacturers, and healthcare providers. These entities invest in research and development activities to improve iron formulations, conduct clinical trials, and provide high-quality products to meet the growing demand.
It’s important to note that the use of intravenous iron therapy should be guided by healthcare professionals and tailored to the individual patient’s needs. Proper assessment, diagnosis, and monitoring of iron levels are essential to determine the appropriate dose and duration of treatment.
In summary, the global intravenous iron therapy market is driven by factors such as the high prevalence of iron deficiency anemia, increasing awareness of the benefits of intravenous iron therapy, and developments in iron formulations. The market is expected to grow as the demand for effective iron supplementation options continues to rise, especially among patients who cannot tolerate or have not responded to oral iron therapy.
Iron is considered as an essential element which plays an important role in many vital biological processes such as the formation of myoglobin, neurotransmitter production, energy metabolism, the formation of collagen and immune system function, and others.Intravenous Iron Therapy is usually preferred over oral iron therapy. This is majorly due to the advantages of intravenous iron therapy, such as faster and higher increase in hemoglobin (Hb) levels and replenishment of body iron stores.
This report studies the global Intravenous Iron Therapy demand, key companies, and key regions.
This report is a detailed and comprehensive analysis of the world market for Intravenous Iron Therapy, and provides market size (US$ million) and Year-over-Year (YoY) growth, considering 2022 as the base year. This report explores demand trends and competition, as well as details the characteristics of Intravenous Iron Therapy that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global Intravenous Iron Therapy total market, 2018-2029, (USD Million)
Global Intravenous Iron Therapy total market by region & country, CAGR, 2018-2029, (USD Million)
U.S. VS China: Intravenous Iron Therapy total market, key domestic companies and share, (USD Million)
Global Intravenous Iron Therapy revenue by player and market share 2018-2023, (USD Million)
Global Intravenous Iron Therapy total market by Type, CAGR, 2018-2029, (USD Million)
Global Intravenous Iron Therapy total market by Application, CAGR, 2018-2029, (USD Million).
This reports profiles major players in the global Intravenous Iron Therapy market based on the following parameters – company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include American Regent, Inc., AMAG Pharmaceuticals, Inc, Fresenius Medical Care, Actavis Pharma, Inc., Sanofi S.A., Vifor Pharma, Pharmacosmos, Rockwell Medical and Allergan, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Intravenous Iron Therapy market.
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), by player, by regions, by Type, and by Application. Data is given for the years 2018-2029 by year with 2022 as the base year, 2023 as the estimate year, and 2024-2029 as the forecast year.
Global Intravenous Iron Therapy Market, By Region:
United States
China
Europe
Japan
South Korea
ASEAN
India
Rest of World
Global Intravenous Iron Therapy Market, Segmentation by Type
Iron Sucrose
Ferric Gluconate
Ferric Carboxymaltose
Ferumoxytol
Others
Global Intravenous Iron Therapy Market, Segmentation by Application
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
Others
Companies Profiled:
American Regent, Inc.
AMAG Pharmaceuticals, Inc
Fresenius Medical Care
Actavis Pharma, Inc.
Sanofi S.A.
Vifor Pharma
Pharmacosmos
Rockwell Medical
Allergan
Galenica Group
Daiichi Sankyo
Shield Therapeutics
Key Questions Answered
1. How big is the global Intravenous Iron Therapy market?
2. What is the demand of the global Intravenous Iron Therapy market?
3. What is the year over year growth of the global Intravenous Iron Therapy market?
4. What is the total value of the global Intravenous Iron Therapy market?
5. Who are the major players in the global Intravenous Iron Therapy market?
Table of Contents
1 Supply Summary
1.1 Intravenous Iron Therapy Introduction
1.2 World Intravenous Iron Therapy Market Size & Forecast (2018 & 2022 & 2029)
1.3 World Intravenous Iron Therapy Total Market by Region (by Headquarter Location)
1.3.1 World Intravenous Iron Therapy Market Size by Region (2018-2029), (by Headquarter Location)
1.3.2 United States Intravenous Iron Therapy Market Size (2018-2029)
1.3.3 China Intravenous Iron Therapy Market Size (2018-2029)
1.3.4 Europe Intravenous Iron Therapy Market Size (2018-2029)
1.3.5 Japan Intravenous Iron Therapy Market Size (2018-2029)
1.3.6 South Korea Intravenous Iron Therapy Market Size (2018-2029)
1.3.7 ASEAN Intravenous Iron Therapy Market Size (2018-2029)
1.3.8 India Intravenous Iron Therapy Market Size (2018-2029)
1.4 Market Drivers, Restraints and Trends
1.4.1 Intravenous Iron Therapy Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Intravenous Iron Therapy Major Market Trends
2 Demand Summary
2.1 World Intravenous Iron Therapy Consumption Value (2018-2029)
2.2 World Intravenous Iron Therapy Consumption Value by Region
2.2.1 World Intravenous Iron Therapy Consumption Value by Region (2018-2023)
2.2.2 World Intravenous Iron Therapy Consumption Value Forecast by Region (2024-2029)
2.3 United States Intravenous Iron Therapy Consumption Value (2018-2029)
2.4 China Intravenous Iron Therapy Consumption Value (2018-2029)
2.5 Europe Intravenous Iron Therapy Consumption Value (2018-2029)
2.6 Japan Intravenous Iron Therapy Consumption Value (2018-2029)
2.7 South Korea Intravenous Iron Therapy Consumption Value (2018-2029)
2.8 ASEAN Intravenous Iron Therapy Consumption Value (2018-2029)
2.9 India Intravenous Iron Therapy Consumption Value (2018-2029)
3 World Intravenous Iron Therapy Companies Competitive Analysis
3.1 World Intravenous Iron Therapy Revenue by Player (2018-2023)
3.2 Industry Rank and Concentration Rate (CR)
3.2.1 Global Intravenous Iron Therapy Industry Rank of Major Players
3.2.2 Global Concentration Ratios (CR4) for Intravenous Iron Therapy in 2022
3.2.3 Global Concentration Ratios (CR8) for Intravenous Iron Therapy in 2022
3.3 Intravenous Iron Therapy Company Evaluation Quadrant
3.4 Intravenous Iron Therapy Market: Overall Company Footprint Analysis
3.4.1 Intravenous Iron Therapy Market: Region Footprint
3.4.2 Intravenous Iron Therapy Market: Company Product Type Footprint
3.4.3 Intravenous Iron Therapy Market: Company Product Application Footprint
3.5 Competitive Environment
3.5.1 Historical Structure of the Industry
3.5.2 Barriers of Market Entry
3.5.3 Factors of Competition
3.6 Mergers, Acquisitions Activity
4 United States VS China VS Rest of the World (by Headquarter Location)
4.1 United States VS China: Intravenous Iron Therapy Revenue Comparison (by Headquarter Location)
4.1.1 United States VS China: Intravenous Iron Therapy Market Size Comparison (2018 & 2022 & 2029) (by Headquarter Location)
4.1.2 United States VS China: Intravenous Iron Therapy Revenue Market Share Comparison (2018 & 2022 & 2029)
4.2 United States Based Companies VS China Based Companies: Intravenous Iron Therapy Consumption Value Comparison
4.2.1 United States VS China: Intravenous Iron Therapy Consumption Value Comparison (2018 & 2022 & 2029)
4.2.2 United States VS China: Intravenous Iron Therapy Consumption Value Market Share Comparison (2018 & 2022 & 2029)
4.3 United States Based Intravenous Iron Therapy Companies and Market Share, 2018-2023
4.3.1 United States Based Intravenous Iron Therapy Companies, Headquarters (States, Country)
4.3.2 United States Based Companies Intravenous Iron Therapy Revenue, (2018-2023)
4.4 China Based Companies Intravenous Iron Therapy Revenue and Market Share, 2018-2023
4.4.1 China Based Intravenous Iron Therapy Companies, Company Headquarters (Province, Country)
4.4.2 China Based Companies Intravenous Iron Therapy Revenue, (2018-2023)
4.5 Rest of World Based Intravenous Iron Therapy Companies and Market Share, 2018-2023
4.5.1 Rest of World Based Intravenous Iron Therapy Companies, Headquarters (States, Country)
4.5.2 Rest of World Based Companies Intravenous Iron Therapy Revenue, (2018-2023)
5 Market Analysis by Type
5.1 World Intravenous Iron Therapy Market Size Overview by Type: 2018 VS 2022 VS 2029
5.2 Segment Introduction by Type
5.2.1 Iron Sucrose
5.2.2 Ferric Gluconate
5.2.3 Ferric Carboxymaltose
5.2.4 Ferumoxytol
5.2.5 Others
5.3 Market Segment by Type
5.3.1 World Intravenous Iron Therapy Market Size by Type (2018-2023)
5.3.2 World Intravenous Iron Therapy Market Size by Type (2024-2029)
5.3.3 World Intravenous Iron Therapy Market Size Market Share by Type (2018-2029)
6 Market Analysis by Application
6.1 World Intravenous Iron Therapy Market Size Overview by Application: 2018 VS 2022 VS 2029
6.2 Segment Introduction by Application
6.2.1 Hospital Pharmacies
6.2.2 Retail Pharmacies
6.2.3 Online Pharmacies
6.2.4 Others
6.2.5 Others
6.3 Market Segment by Application
6.3.1 World Intravenous Iron Therapy Market Size by Application (2018-2023)
6.3.2 World Intravenous Iron Therapy Market Size by Application (2024-2029)
6.3.3 World Intravenous Iron Therapy Market Size by Application (2018-2029)
7 Company Profiles
7.1 American Regent, Inc.
7.1.1 American Regent, Inc. Details
7.1.2 American Regent, Inc. Major Business
7.1.3 American Regent, Inc. Intravenous Iron Therapy Product and Services
7.1.4 American Regent, Inc. Intravenous Iron Therapy Revenue, Gross Margin and Market Share (2018-2023)
7.1.5 American Regent, Inc. Recent Developments/Updates
7.1.6 American Regent, Inc. Competitive Strengths & Weaknesses
7.2 AMAG Pharmaceuticals, Inc
7.2.1 AMAG Pharmaceuticals, Inc Details
7.2.2 AMAG Pharmaceuticals, Inc Major Business
7.2.3 AMAG Pharmaceuticals, Inc Intravenous Iron Therapy Product and Services
7.2.4 AMAG Pharmaceuticals, Inc Intravenous Iron Therapy Revenue, Gross Margin and Market Share (2018-2023)
7.2.5 AMAG Pharmaceuticals, Inc Recent Developments/Updates
7.2.6 AMAG Pharmaceuticals, Inc Competitive Strengths & Weaknesses
7.3 Fresenius Medical Care
7.3.1 Fresenius Medical Care Details
7.3.2 Fresenius Medical Care Major Business
7.3.3 Fresenius Medical Care Intravenous Iron Therapy Product and Services
7.3.4 Fresenius Medical Care Intravenous Iron Therapy Revenue, Gross Margin and Market Share (2018-2023)
7.3.5 Fresenius Medical Care Recent Developments/Updates
7.3.6 Fresenius Medical Care Competitive Strengths & Weaknesses
7.4 Actavis Pharma, Inc.
7.4.1 Actavis Pharma, Inc. Details
7.4.2 Actavis Pharma, Inc. Major Business
7.4.3 Actavis Pharma, Inc. Intravenous Iron Therapy Product and Services
7.4.4 Actavis Pharma, Inc. Intravenous Iron Therapy Revenue, Gross Margin and Market Share (2018-2023)
7.4.5 Actavis Pharma, Inc. Recent Developments/Updates
7.4.6 Actavis Pharma, Inc. Competitive Strengths & Weaknesses
7.5 Sanofi S.A.
7.5.1 Sanofi S.A. Details
7.5.2 Sanofi S.A. Major Business
7.5.3 Sanofi S.A. Intravenous Iron Therapy Product and Services
7.5.4 Sanofi S.A. Intravenous Iron Therapy Revenue, Gross Margin and Market Share (2018-2023)
7.5.5 Sanofi S.A. Recent Developments/Updates
7.5.6 Sanofi S.A. Competitive Strengths & Weaknesses
7.6 Vifor Pharma
7.6.1 Vifor Pharma Details
7.6.2 Vifor Pharma Major Business
7.6.3 Vifor Pharma Intravenous Iron Therapy Product and Services
7.6.4 Vifor Pharma Intravenous Iron Therapy Revenue, Gross Margin and Market Share (2018-2023)
7.6.5 Vifor Pharma Recent Developments/Updates
7.6.6 Vifor Pharma Competitive Strengths & Weaknesses
7.7 Pharmacosmos
7.7.1 Pharmacosmos Details
7.7.2 Pharmacosmos Major Business
7.7.3 Pharmacosmos Intravenous Iron Therapy Product and Services
7.7.4 Pharmacosmos Intravenous Iron Therapy Revenue, Gross Margin and Market Share (2018-2023)
7.7.5 Pharmacosmos Recent Developments/Updates
7.7.6 Pharmacosmos Competitive Strengths & Weaknesses
7.8 Rockwell Medical
7.8.1 Rockwell Medical Details
7.8.2 Rockwell Medical Major Business
7.8.3 Rockwell Medical Intravenous Iron Therapy Product and Services
7.8.4 Rockwell Medical Intravenous Iron Therapy Revenue, Gross Margin and Market Share (2018-2023)
7.8.5 Rockwell Medical Recent Developments/Updates
7.8.6 Rockwell Medical Competitive Strengths & Weaknesses
7.9 Allergan
7.9.1 Allergan Details
7.9.2 Allergan Major Business
7.9.3 Allergan Intravenous Iron Therapy Product and Services
7.9.4 Allergan Intravenous Iron Therapy Revenue, Gross Margin and Market Share (2018-2023)
7.9.5 Allergan Recent Developments/Updates
7.9.6 Allergan Competitive Strengths & Weaknesses
7.10 Galenica Group
7.10.1 Galenica Group Details
7.10.2 Galenica Group Major Business
7.10.3 Galenica Group Intravenous Iron Therapy Product and Services
7.10.4 Galenica Group Intravenous Iron Therapy Revenue, Gross Margin and Market Share (2018-2023)
7.10.5 Galenica Group Recent Developments/Updates
7.10.6 Galenica Group Competitive Strengths & Weaknesses
7.11 Daiichi Sankyo
7.11.1 Daiichi Sankyo Details
7.11.2 Daiichi Sankyo Major Business
7.11.3 Daiichi Sankyo Intravenous Iron Therapy Product and Services
7.11.4 Daiichi Sankyo Intravenous Iron Therapy Revenue, Gross Margin and Market Share (2018-2023)
7.11.5 Daiichi Sankyo Recent Developments/Updates
7.11.6 Daiichi Sankyo Competitive Strengths & Weaknesses
7.12 Shield Therapeutics
7.12.1 Shield Therapeutics Details
7.12.2 Shield Therapeutics Major Business
7.12.3 Shield Therapeutics Intravenous Iron Therapy Product and Services
7.12.4 Shield Therapeutics Intravenous Iron Therapy Revenue, Gross Margin and Market Share (2018-2023)
7.12.5 Shield Therapeutics Recent Developments/Updates
7.12.6 Shield Therapeutics Competitive Strengths & Weaknesses
8 Industry Chain Analysis
8.1 Intravenous Iron Therapy Industry Chain
8.2 Intravenous Iron Therapy Upstream Analysis
8.3 Intravenous Iron Therapy Midstream Analysis
8.4 Intravenous Iron Therapy Downstream Analysis
9 Research Findings and Conclusion
10 Appendix
10.1 Methodology
10.2 Research Process and Data Source
10.3 Disclaimer
Table of Figures
List of Tables
Table 1. World Intravenous Iron Therapy Revenue by Region (2018, 2022 and 2029) & (USD Million), (by Headquarter Location)
Table 2. World Intravenous Iron Therapy Revenue by Region (2018-2023) & (USD Million), (by Headquarter Location)
Table 3. World Intravenous Iron Therapy Revenue by Region (2024-2029) & (USD Million), (by Headquarter Location)
Table 4. World Intravenous Iron Therapy Revenue Market Share by Region (2018-2023), (by Headquarter Location)
Table 5. World Intravenous Iron Therapy Revenue Market Share by Region (2024-2029), (by Headquarter Location)
Table 6. Major Market Trends
Table 7. World Intravenous Iron Therapy Consumption Value Growth Rate Forecast by Region (2018 & 2022 & 2029) & (USD Million)
Table 8. World Intravenous Iron Therapy Consumption Value by Region (2018-2023) & (USD Million)
Table 9. World Intravenous Iron Therapy Consumption Value Forecast by Region (2024-2029) & (USD Million)
Table 10. World Intravenous Iron Therapy Revenue by Player (2018-2023) & (USD Million)
Table 11. Revenue Market Share of Key Intravenous Iron Therapy Players in 2022
Table 12. World Intravenous Iron Therapy Industry Rank of Major Player, Based on Revenue in 2022
Table 13. Global Intravenous Iron Therapy Company Evaluation Quadrant
Table 14. Head Office of Key Intravenous Iron Therapy Player
Table 15. Intravenous Iron Therapy Market: Company Product Type Footprint
Table 16. Intravenous Iron Therapy Market: Company Product Application Footprint
Table 17. Intravenous Iron Therapy Mergers & Acquisitions Activity
Table 18. United States VS China Intravenous Iron Therapy Market Size Comparison, (2018 & 2022 & 2029) & (USD Million)
Table 19. United States VS China Intravenous Iron Therapy Consumption Value Comparison, (2018 & 2022 & 2029) & (USD Million)
Table 20. United States Based Intravenous Iron Therapy Companies, Headquarters (States, Country)
Table 21. United States Based Companies Intravenous Iron Therapy Revenue, (2018-2023) & (USD Million)
Table 22. United States Based Companies Intravenous Iron Therapy Revenue Market Share (2018-2023)
Table 23. China Based Intravenous Iron Therapy Companies, Headquarters (Province, Country)
Table 24. China Based Companies Intravenous Iron Therapy Revenue, (2018-2023) & (USD Million)
Table 25. China Based Companies Intravenous Iron Therapy Revenue Market Share (2018-2023)
Table 26. Rest of World Based Intravenous Iron Therapy Companies, Headquarters (States, Country)
Table 27. Rest of World Based Companies Intravenous Iron Therapy Revenue, (2018-2023) & (USD Million)
Table 28. Rest of World Based Companies Intravenous Iron Therapy Revenue Market Share (2018-2023)
Table 29. World Intravenous Iron Therapy Market Size by Type, (USD Million), 2018 & 2022 & 2029
Table 30. World Intravenous Iron Therapy Market Size by Type (2018-2023) & (USD Million)
Table 31. World Intravenous Iron Therapy Market Size by Type (2024-2029) & (USD Million)
Table 32. World Intravenous Iron Therapy Market Size by Application, (USD Million), 2018 & 2022 & 2029
Table 33. World Intravenous Iron Therapy Market Size by Application (2018-2023) & (USD Million)
Table 34. World Intravenous Iron Therapy Market Size by Application (2024-2029) & (USD Million)
Table 35. American Regent, Inc. Basic Information, Area Served and Competitors
Table 36. American Regent, Inc. Major Business
Table 37. American Regent, Inc. Intravenous Iron Therapy Product and Services
Table 38. American Regent, Inc. Intravenous Iron Therapy Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 39. American Regent, Inc. Recent Developments/Updates
Table 40. American Regent, Inc. Competitive Strengths & Weaknesses
Table 41. AMAG Pharmaceuticals, Inc Basic Information, Area Served and Competitors
Table 42. AMAG Pharmaceuticals, Inc Major Business
Table 43. AMAG Pharmaceuticals, Inc Intravenous Iron Therapy Product and Services
Table 44. AMAG Pharmaceuticals, Inc Intravenous Iron Therapy Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 45. AMAG Pharmaceuticals, Inc Recent Developments/Updates
Table 46. AMAG Pharmaceuticals, Inc Competitive Strengths & Weaknesses
Table 47. Fresenius Medical Care Basic Information, Area Served and Competitors
Table 48. Fresenius Medical Care Major Business
Table 49. Fresenius Medical Care Intravenous Iron Therapy Product and Services
Table 50. Fresenius Medical Care Intravenous Iron Therapy Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 51. Fresenius Medical Care Recent Developments/Updates
Table 52. Fresenius Medical Care Competitive Strengths & Weaknesses
Table 53. Actavis Pharma, Inc. Basic Information, Area Served and Competitors
Table 54. Actavis Pharma, Inc. Major Business
Table 55. Actavis Pharma, Inc. Intravenous Iron Therapy Product and Services
Table 56. Actavis Pharma, Inc. Intravenous Iron Therapy Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 57. Actavis Pharma, Inc. Recent Developments/Updates
Table 58. Actavis Pharma, Inc. Competitive Strengths & Weaknesses
Table 59. Sanofi S.A. Basic Information, Area Served and Competitors
Table 60. Sanofi S.A. Major Business
Table 61. Sanofi S.A. Intravenous Iron Therapy Product and Services
Table 62. Sanofi S.A. Intravenous Iron Therapy Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 63. Sanofi S.A. Recent Developments/Updates
Table 64. Sanofi S.A. Competitive Strengths & Weaknesses
Table 65. Vifor Pharma Basic Information, Area Served and Competitors
Table 66. Vifor Pharma Major Business
Table 67. Vifor Pharma Intravenous Iron Therapy Product and Services
Table 68. Vifor Pharma Intravenous Iron Therapy Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 69. Vifor Pharma Recent Developments/Updates
Table 70. Vifor Pharma Competitive Strengths & Weaknesses
Table 71. Pharmacosmos Basic Information, Area Served and Competitors
Table 72. Pharmacosmos Major Business
Table 73. Pharmacosmos Intravenous Iron Therapy Product and Services
Table 74. Pharmacosmos Intravenous Iron Therapy Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 75. Pharmacosmos Recent Developments/Updates
Table 76. Pharmacosmos Competitive Strengths & Weaknesses
Table 77. Rockwell Medical Basic Information, Area Served and Competitors
Table 78. Rockwell Medical Major Business
Table 79. Rockwell Medical Intravenous Iron Therapy Product and Services
Table 80. Rockwell Medical Intravenous Iron Therapy Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 81. Rockwell Medical Recent Developments/Updates
Table 82. Rockwell Medical Competitive Strengths & Weaknesses
Table 83. Allergan Basic Information, Area Served and Competitors
Table 84. Allergan Major Business
Table 85. Allergan Intravenous Iron Therapy Product and Services
Table 86. Allergan Intravenous Iron Therapy Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 87. Allergan Recent Developments/Updates
Table 88. Allergan Competitive Strengths & Weaknesses
Table 89. Galenica Group Basic Information, Area Served and Competitors
Table 90. Galenica Group Major Business
Table 91. Galenica Group Intravenous Iron Therapy Product and Services
Table 92. Galenica Group Intravenous Iron Therapy Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 93. Galenica Group Recent Developments/Updates
Table 94. Galenica Group Competitive Strengths & Weaknesses
Table 95. Daiichi Sankyo Basic Information, Area Served and Competitors
Table 96. Daiichi Sankyo Major Business
Table 97. Daiichi Sankyo Intravenous Iron Therapy Product and Services
Table 98. Daiichi Sankyo Intravenous Iron Therapy Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 99. Daiichi Sankyo Recent Developments/Updates
Table 100. Shield Therapeutics Basic Information, Area Served and Competitors
Table 101. Shield Therapeutics Major Business
Table 102. Shield Therapeutics Intravenous Iron Therapy Product and Services
Table 103. Shield Therapeutics Intravenous Iron Therapy Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 104. Global Key Players of Intravenous Iron Therapy Upstream (Raw Materials)
Table 105. Intravenous Iron Therapy Typical Customers
List of Figure
Figure 1. Intravenous Iron Therapy Picture
Figure 2. World Intravenous Iron Therapy Total Market Size: 2018 & 2022 & 2029, (USD Million)
Figure 3. World Intravenous Iron Therapy Total Market Size (2018-2029) & (USD Million)
Figure 4. World Intravenous Iron Therapy Revenue Market Share by Region (2018, 2022 and 2029) & (USD Million) , (by Headquarter Location)
Figure 5. World Intravenous Iron Therapy Revenue Market Share by Region (2018-2029), (by Headquarter Location)
Figure 6. United States Based Company Intravenous Iron Therapy Revenue (2018-2029) & (USD Million)
Figure 7. China Based Company Intravenous Iron Therapy Revenue (2018-2029) & (USD Million)
Figure 8. Europe Based Company Intravenous Iron Therapy Revenue (2018-2029) & (USD Million)
Figure 9. Japan Based Company Intravenous Iron Therapy Revenue (2018-2029) & (USD Million)
Figure 10. South Korea Based Company Intravenous Iron Therapy Revenue (2018-2029) & (USD Million)
Figure 11. ASEAN Based Company Intravenous Iron Therapy Revenue (2018-2029) & (USD Million)
Figure 12. India Based Company Intravenous Iron Therapy Revenue (2018-2029) & (USD Million)
Figure 13. Intravenous Iron Therapy Market Drivers
Figure 14. Factors Affecting Demand
Figure 15. World Intravenous Iron Therapy Consumption Value (2018-2029) & (USD Million)
Figure 16. World Intravenous Iron Therapy Consumption Value Market Share by Region (2018-2029)
Figure 17. United States Intravenous Iron Therapy Consumption Value (2018-2029) & (USD Million)
Figure 18. China Intravenous Iron Therapy Consumption Value (2018-2029) & (USD Million)
Figure 19. Europe Intravenous Iron Therapy Consumption Value (2018-2029) & (USD Million)
Figure 20. Japan Intravenous Iron Therapy Consumption Value (2018-2029) & (USD Million)
Figure 21. South Korea Intravenous Iron Therapy Consumption Value (2018-2029) & (USD Million)
Figure 22. ASEAN Intravenous Iron Therapy Consumption Value (2018-2029) & (USD Million)
Figure 23. India Intravenous Iron Therapy Consumption Value (2018-2029) & (USD Million)
Figure 24. Producer Shipments of Intravenous Iron Therapy by Player Revenue ($MM) and Market Share (%): 2022
Figure 25. Global Four-firm Concentration Ratios (CR4) for Intravenous Iron Therapy Markets in 2022
Figure 26. Global Four-firm Concentration Ratios (CR8) for Intravenous Iron Therapy Markets in 2022
Figure 27. United States VS China: Intravenous Iron Therapy Revenue Market Share Comparison (2018 & 2022 & 2029)
Figure 28. United States VS China: Intravenous Iron Therapy Consumption Value Market Share Comparison (2018 & 2022 & 2029)
Figure 29. World Intravenous Iron Therapy Market Size by Type, (USD Million), 2018 & 2022 & 2029
Figure 30. World Intravenous Iron Therapy Market Size Market Share by Type in 2022
Figure 31. Iron Sucrose
Figure 32. Ferric Gluconate
Figure 33. Ferric Carboxymaltose
Figure 34. Ferumoxytol
Figure 35. Others
Figure 36. World Intravenous Iron Therapy Market Size Market Share by Type (2018-2029)
Figure 37. World Intravenous Iron Therapy Market Size by Application, (USD Million), 2018 & 2022 & 2029
Figure 38. World Intravenous Iron Therapy Market Size Market Share by Application in 2022
Figure 39. Hospital Pharmacies
Figure 40. Retail Pharmacies
Figure 41. Online Pharmacies
Figure 42. Others
Figure 43. Intravenous Iron Therapy Industrial Chain
Figure 44. Methodology
Figure 45. Research Process and Data Source
Research Methodology
Client Requirements
Review and analyze client requirements
Discussion of all the project requirements and queries
Flexibility Check
Project Feasibility Analysis
Finalizing tentative research programme
Structuring project proposal with scope, timeline, and costs
Analyzing Market Dynamics
Determination of key drivers, restraints, challenge, and opportunity
Identifies market needs and trends
Market Size Estimation & Forecast
Estimation of historical data based on secondary and primary data
Anticipating market recast by assigning weightage to market forces (drivers, restraints, opportunities)
Freezing historical and forecast market size estimations based on evolution, trends, outlook, and strategies
Consideration of geography, region-specific product/service demand for region segments
Consideration of product utilization rates, product demand outlook for segments by application or end-user.
Data Source
Secondary Source
Data collections from annual reports, presentations,associations, journals, analyst reports,
paid database, press releases, blogs, newsletters,and GIR repositories.
Primary Source
Research discussion with manufacturers, distributors, suppliers, end user, industry experts
to verify insights.
Validation
and
triangulation of
secondary and primary source.
Collection of data
Cumulating and collating the essential qualitative and quantitative data
Generation of report in client requested format by research analysts
Reviews by expert analysts
Final quality check
Clarifying queries
Receiving feedback
Ensuring satisfaction
01 Identification of data
This step involves identification of several primary and secondary data research sources, including Global Info Research's internal data sources. The primary sources consist of in-depth discussions and interviews with policy makers, industry experts, and data evaluators, whereas secondary sources include a thorough study of market journals, press releases, annual reports, and government and non-government agencies websites.
02 Evaluation of Market Dynamic
This phase includes a detailed evaluation of several factors that are likely to affect the market dynamics. It involves a comprehensive assessment of major market pain points, drivers, and trends. It also comprises a detailed study of research plans and methodology.
03 Collection of Data
This process consists of gathering data, accessing proprietary databases, and reaching out to key industry participants that operate in the market across the value chain. It also involves studying several patterns in the historical data and comparing it with the current scenario.
04 Collaboration of Data
This stage involves the validation of data and arrival at actual statistics, and evolution of the market over the years. It entails the study and analyzes various segments and verticals of the market. An impact analysis is also performed to observe which factors will affect the market in the next few years.
05 Verification and Analysis
This is the final stage, which involves both quantity and quality checks. Although the process of data verification is an integral part of the research process, all data points and statistics and figures are re-checked to uphold their authenticity and validity.
Companies Mentioned
American Regent, Inc. AMAG Pharmaceuticals, Inc Fresenius Medical Care Actavis Pharma, Inc. Sanofi S.A. Vifor Pharma Pharmacosmos Rockwell Medical Allergan Galenica Group Daiichi Sankyo Shield Therapeutics
Related Reports
Purchase Options
Add To Cart
Buy Now
Popular Product Keywords
- We Provide Professional, Accurate Market Analysis to Help You Stay Ahead of Your Competition.Speak to our analyst >>
Our Clients
What We Can Provide?
With better results and higher quality products,Our professional reports can achieve four things:
-
Insight into the industry market information
-
Analyze market development needs
-
Prospects for future development
-
Develop industry investment strategy
-
- Digging deeper into global industry information and providing market strategies.Contact Us >>